Shares of ENvue Medical, Inc. (NASDAQ:FEED) are surging on Tuesday after the company disclosed a new hospital system win that lifts its U.S. footprint to 39 hospitals, including a 714-bed teaching facility and Level I Trauma Center in the Detroit metro area.

Michigan Hospital Purchases ENvue Navigation Platform

ENvue Medical's catalyst is a fresh purchase of its ENvue Navigation Platform and feeding tubes by a teaching hospital and Level I Trauma Center in Southeast Michigan, expanding an existing relationship within that health system and taking the company's U.S. hospital footprint to 39.

The platform is FDA 510(k) cleared for adult use and provides real-time bedside visualization of tube movement, with management emphasizing "greater standardization" in feeding tube placement as hospitals prioritize safety and workflow integration.

That hospital-driven update is why FEED is acting like a momentum name today, with the stock up 55.26% at $2.22 at the time of publication. Traders are also keying off the company's push toward strategic account expansion nationwide, alongside longer-run platform expansion targets that include pediatric and vascular access applications.

ENvue Medical develops medical devices that help clinicians navigate feeding-tube placement more safely and efficiently. Its ENvue system uses smart feeding tubes with sensors, body mapping, and continuous visual guidance to confirm positioning and reduce complications like lung misplacement.

From a chart perspective, the move looks like a sharp rebound attempt after a weak stretch, with traders focusing on whether price can hold above key short-term trend gauges. The next question is whether this pop becomes a trend change—or just a fast mean-reversion bounce inside a longer downtrend.

FEED Stock Soars Above Key Averages

ENvue Medical is trading 25.3% above its 20-day SMA ($1.83) and 8.2% above its 50-day SMA ($2.12), which shows strong short-term thrust even though the 20-day SMA remains below the 50-day SMA (a bearish alignment that often signals the bigger trend hasn't fully healed). Shares are down 44.15% over the past 12 months, and the stock is positioned closer to its 52-week low (99 cents) than its 52-week high ($6.09).

Momentum gauges still aren't fully confirming a clean bullish turn: RSI is at 37.74, which is considered neutral territory but closer to the "weak" side of the range. Meanwhile, MACD is at -0.2859 versus a signal line of -0.2339, keeping the indicator bearish with a histogram at -0.0520.

The combination of RSI in the 30–50 range and bearish MACD suggests mixed momentum.

  • Key Resistance: $2.50
  • Key Support: $2.00

FEED Stock Soars Tuesday

FEED Stock Price Activity: ENvue Medical shares were up 51.05% at $2.16 at the time of publication on Tuesday, according to Benzinga Pro data.

Image: Shutterstock